Lombardi, Carlo http://orcid.org/0000-0002-7120-5877
Comberiati, Pasquale http://orcid.org/0000-0001-5209-9733
Ridolo, Erminia http://orcid.org/0000-0003-1439-7902
Cottini, Marcello http://orcid.org/0000-0003-2767-6767
Yacoub, Mona Rita http://orcid.org/0000-0003-2417-0410
Casagrande, Silvia http://orcid.org/0000-0002-4111-1810
Riccò, Matteo http://orcid.org/0000-0002-6525-2159
Bottazzoli, Marco http://orcid.org/0000-0003-0888-9521
Berti, Alvise http://orcid.org/0000-0002-7831-921X
Funding for this research was provided by:
UniversitĂ degli Studi di Trento
Article History
Accepted: 24 April 2024
First Online: 8 June 2024
Declarations
:
: Open access funding provided by UniversitĂ degli Studi di Trento within the CRUI-CARE Agreement.
: Alvise Berti received funding from GSK (advisory boards, speaker fees). Overall, the authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: AB, CL, and PC designed the study and harmonized each section. All the authors drafted the manuscript. AB prepared all the figures. All coauthors interpreted the results and analyzed critically the manuscript for important intellectual content and approved the final version.